MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    THE ABILITY OF PATIENTS WITH PARKINSON’S DISEASE TO RECOGNIZE MASKED FACES DURING COVID-19 PANDEMIC

    S. Tezcan Aydemir, M. Kuzu Kumcu, N. Durmaz çelik, B. Bakirarar, S. özkan, M. Akbostancı (Ankara, Turkey)

    Objective: This study aims to evaluate the effect of using masks on face recognition ability in Patients with Parkinson’s disease (PwP). Background: Patients with Parkinson’s…
  • MDS Virtual Congress 2021

    Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.

    P. Beach, J. Mckay (Atlanta, USA)

    Objective: To assess prevalence of neurogenic and peripheral orthostatic hypotension (nOH/pOH) in the PPMI (https://www.ppmi-info.org) idiopathic Parkinson disease (PD) cohort and to examine whether nOH,…
  • MDS Virtual Congress 2021

    Evaluation of cognitive function in patients with Essential Tremor in Mexican population

    A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga, H. Estrada-Rodriguez, L. Gaibor-Noboa, D. Vazquez-Guevara (Mexico City, Mexico)

    Objective: Objective: Evaluate cognitive functions with a neuropsychological test in patients with Essential Tremor attending the Movement Disorders Unit at the National Institute of Neurology…
  • MDS Virtual Congress 2021

    Visual cognition differences between asymptomatic and symptomatic carriers of Huntington’s disease (HD)

    M. Turuelo, MA. Acera, M. Diez-Cirarda, T. Fernández, B. Tijero, M. Carmona, M. Ruiz, J. Somme, J. Ruiz, A. Gabilondo, I. Croitoru, L. Pardina, N. Ayo, A. Murueta-Goyena, I. Gabilondo, JC. Gómez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: This study aims to analyze the visual cognition profile of asymptomatic and symptomatic carriers of Huntington's disease (HD), compared with healthy controls (HC), and…
  • MDS Virtual Congress 2021

    Informant vs. Self-ratings of Activities of Daily Living in Parkinson’s Disease patients

    S. Becker, S. Nussbaum, K. Michaelis, K. Brockmann, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To compare patient and informant ratings of impairments in activities of daily living (ADL) of Parkinson’s Disease (PD) patients. Background: Valid ratings of ADL…
  • MDS Virtual Congress 2021

    Cognitive-driven ADL impairment as a predictor for PDD

    I. Liepelt-Scarfone, M. Bode, K. Brockmann, T. Gasser, K. Michaelis, S. Nussbaum, HC. Nuerk, C. Schulte, W. Maetzler, M. Zimmermann, D. Berg, S. Becker (Tübingen, Germany)

    Objective: To evaluate whether Parkinson’s disease (PD) patients with mild activity of daily living (ADL) impairment are at higher risk for developing dementia (PDD). Background:…
  • MDS Virtual Congress 2021

    Effects of dopaminergic medication on reinforcement learning in Parkinson’s disease depend on depressive symptoms

    J. Tichelaar, C. Sayali, R. Helmich, R. Cools (Nijmegen, Netherlands)

    Objective: To investigate the effect of depression and dopaminergic medication on reinforcement learning (RL) in Parkinson’s disease. Background: Dopaminergic medication in PD is known to…
  • MDS Virtual Congress 2021

    Links between Cognitive Impairment and Contrast Sensitivity in Parkinson’s Disease

    C. Catiul, R. Memon, A. Memon, A. Joop, J. Pilkington, K. Wood, A. Amara (Birmingham, USA)

    Objective: To evaluate the relationship between Contrast Sensitivity (CS) and cognitive function in patients with idiopathic Parkinson’s Disease (PD) and healthy controls (HC). Background: In…
  • MDS Virtual Congress 2021

    GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS

    K. Adigun, M. Ehinmowo, A. Adebiyi, O. Adebiyi (Ibadan, Nigeria)

    Objective: Bisphenol A (BPA) has been found to exert neurotoxic effects through its neuroendocrine disruption and generation of reactive oxygen species (ROS). It can also…
  • MDS Virtual Congress 2021

    Cognitive assessment of Parkinson’s Disease patients in a Northeast Brazilian population: Current Challenges

    J. Bonfadini, D. Lima, A. Carneiro, J. Luna, A. Damasceno, P. Braga-Neto (Fortaleza, Brazil)

    Objective: To evaluate the influence of education level in the Mini-Mental Status Examination (MMSE) score in Parkinson’s Disease (PD) patients in a northeast Brazilian sample.…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley